Recurrent Adult Immunoblastic Large Cell Lymphoma Completed Phase Trials for Ganciclovir (DB01004)

IndicationStatusPhase
DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01199562Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantSupportive Care